E

Exact Therapeutics AS
OSE:EXTX

Watchlist Manager
Exact Therapeutics AS
OSE:EXTX
Watchlist
Price: 3 NOK
Market Cap: 189.8m NOK

Intrinsic Value

The intrinsic value of one EXTX stock under the Base Case scenario is 1.57 NOK. Compared to the current market price of 3 NOK, Exact Therapeutics AS is Overvalued by 48%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

EXTX Intrinsic Value
1.57 NOK
Overvaluation 48%
Intrinsic Value
Price
E
Worst Case
Base Case
Best Case

Valuation History
Exact Therapeutics AS

What is Valuation History?
Compare EXTX to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about EXTX?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Exact Therapeutics AS
Financials
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Exact Therapeutics AS

Balance Sheet Decomposition
Exact Therapeutics AS

Current Assets 133.2m
Cash & Short-Term Investments 99.5m
Receivables 33.7m
Non-Current Assets 20m
PP&E 4.8m
Other Non-Current Assets 15.2m
Efficiency

Free Cash Flow Analysis
Exact Therapeutics AS

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Exact Therapeutics AS

Revenue
0 NOK
Operating Expenses
-51.4m NOK
Operating Income
-51.4m NOK
Other Expenses
-951.8k NOK
Net Income
-52.3m NOK
Fundamental Scores

EXTX Profitability Score
Profitability Due Diligence

Exact Therapeutics AS's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
27/100
Profitability
Score

Exact Therapeutics AS's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

EXTX Solvency Score
Solvency Due Diligence

Exact Therapeutics AS's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Negative Net Debt
Low D/E
Short-Term Solvency
65/100
Solvency
Score

Exact Therapeutics AS's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

EXTX Price Targets Summary
Exact Therapeutics AS

There are no price targets for EXTX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Exact Therapeutics AS
does not pay dividends
Shareholder Yield

Current shareholder yield for EXTX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one EXTX stock?

The intrinsic value of one EXTX stock under the Base Case scenario is 1.57 NOK.

Is EXTX stock undervalued or overvalued?

Compared to the current market price of 3 NOK, Exact Therapeutics AS is Overvalued by 48%.

Back to Top